Protocol-based cardiotoxicity monitoring in hydroxychloroquine medicated COVID-19 pediatric patients

INTRODUCTION/OBJECTIVES: By May 2020, SARS-CoV-2 had caused more than 400 000 deaths worldwide. Initially, hydroxychloroquine was a treatment option for COVID-19. More recent studies have questioned its safety and efficacy and, until stronger evidence is available, it was suspended from therapy prot...

Descripción completa

Detalles Bibliográficos
Autores principales: Hormigo, Inês, Milheiro Silva, Tiago, Laranjo, Sérgio, Trigo, Conceição, Garcia, Ana Margarida, Gouveia, Catarina, Brito, Maria João
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Portuguesa de Cardiologia. Published by Elsevier España, S.L.U. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455282/
https://www.ncbi.nlm.nih.gov/pubmed/34566257
http://dx.doi.org/10.1016/j.repc.2021.01.018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455282/
https://www.ncbi.nlm.nih.gov/pubmed/34566257
http://dx.doi.org/10.1016/j.repc.2021.01.018

Ejemplares similares